4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Arrhythmogenic right ventricular cardiomyopathy (ARVC) encompasses a group of
conditions characterized by right ventricular fibrofatty infiltration, with a predominant …

Background The clinical presentation of cardiac sarcoidosis (CS) may resemble that of
arrhythmogenic right ventricular cardiomyopathy (ARVC). Objective The purpose of this …

Arrhythmogenic cardiomyopathy (ACM) is a familial, nonischemic heart disease typically
inherited via an autosomal dominant pattern (Nava et al., 1988; Wlodarska et al., 2005) …

Sarcoidosis is a multisystem disorder of unknown etiology. The leading hypothesis involves
an antigen-triggered dysregulated T-cell-driven immunologic response leading to non …

Sarcoidosis is a multisystem granulomatous disease with 2 different phases (inflammation
and scar). In the current era of targeted use of implantable cardioverter-defibrillators and …

Aims Endocardial unipolar and bipolar voltage mapping (UVM/BVM) of the right ventricle
(RV) are used for transmural substrate delineation. However, far-field electrograms (EGMs) …

Aims Cardiac sarcoidosis (CS) is a known cause of ventricular tachycardia (VT). However,
an arrhythmogenic presentation may not prompt immediate comprehensive evaluation. We …